Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study
Roux, C, Hofbauer, L.C, Ho, P.R, Wark, J.D, Zillikens, M.C, Fahrleitner-Pammer, A, Hawkins, F, Micaelo, M, Minisola, S, Papaioannou, N, Stone, M, Ferreira, I, Siddhanti, S, Wagman, R.B, Brown, J.P
Published in Bone (New York, N.Y.) (01.01.2014)
Published in Bone (New York, N.Y.) (01.01.2014)
Get full text
Journal Article
Natalizumab vs fingolimod in patients with active relapsing-remitting multiple sclerosis (RRMS): comparative MRI assessments of disease activity from reveal, a randomized, head-to-head phase 4 study
Licata, S., Butzkueven, H., Jeffery, D., Arnold, D.L., Filippi, M., Geurts, J.J.G., Dong, Q., Campbell, N., Ho, P.R.
Published in Journal of the neurological sciences (15.10.2017)
Published in Journal of the neurological sciences (15.10.2017)
Get full text
Journal Article
MMSE recursive estimation of high phase-noise that is Wiener non-stationary
Get full text
Conference Proceeding
Traitement par denosumab chez des hommes à masse osseuse basse: résultats à 24 mois de l'étude ADAMO
Chapurlat, R., Langdahl, B., Teglbjaerg, C., HO, P.R., Czerwinski, E., Kendler, D., Reginster, Jean-Yves, Kivitz, A., LEWIECKI, E., Miller, P., Bolognese, M., McClung, M., Bone, H., Ljunggren, O., Abrahamsen, B., Gruntmanis, U., Wagman, R., Siddhanti, S., Orwoll, E.
Year of Publication 01.11.2015
Get full text
Year of Publication 01.11.2015
Web Resource
Manchester United vai voltar à bolsa
Por P.R. Venkat e Prudence Ho, de Cingapura
Published in The Wall Street Journal Americas (16.08.2011)
Get full text
Published in The Wall Street Journal Americas (16.08.2011)
Newspaper Article